The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Improving compound–protein interaction prediction by building up highly credible negative samples
Open accessAbstract
Motivation: Computational prediction of compound–protein interactions (CPIs) is of great importance for drug design and development, as genome-scale experimental validation of CPIs is not only time-consuming but also prohibitively expensive. With the availability of an increasing number of validated interactions, the performance of computational prediction approaches is severely impended by the lack of reliable negative CPI samples. A systematic method of screening reliable negative sample becomes critical to improving the performance of in silico prediction methods. Results: This article aims at building up a set of highly credible negative samples of CPIs via an in silico screening method. As most existing computational models assume that similar compounds are likely to interact with similar target proteins and achieve remarkable performance, it is rational to identify potential negative samples based on the converse negative proposition that the proteins dissimilar to every known/predicted target of a compound are not much likely to be targeted by the compound and vice versa. We integrated various resources, including chemical structures, chemical expression profiles and side effects of compounds, amino acid sequences, protein–protein interaction network and functional annotations of proteins, into a systematic screening framework. We first tested the screened negative samples on six classical classifiers, and all these classifiers achieved remarkably higher performance on our negative samples than on randomly generated negative samples for both human and Caenorhabditis elegans. We then verified the negative samples on three existing prediction models, including bipartite local model, Gaussian kernel profile and Bayesian matrix factorization, and found that the performances of these models are also significantly improved on the screened negative samples. Moreover, we validated the screened negative samples on a drug bioactivity dataset. Finally, we derived two sets of new interactions by training an support vector machine classifier on the positive interactions annotated in DrugBank and our screened negative interactions. The screened negative samples and the predicted interactions provide the research community with a useful resource for identifying new drug targets and a helpful supplement to the current curated compound–protein databases. Availability: Supplementary files are available at: http://admis.fudan.edu.cn/negative-cpi/. Contact: sgzhou@fudan.edu.cn Supplementary Information: Supplementary data are available at Bioinformatics online.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
LIBSVM: A library for support vector machines
Chang, C.-C., & Lin, C.-J. (2011) · ACM Transactions on Intelligent Systems and Technology · doi:10.1145/1961189.1961199 · Cited by 40,918
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
The Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
Identification of common molecular subsequences
Smith, T. F., & Waterman, M. S. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90087-5 · Cited by 9,940
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
The Pfam protein families database
Punta, M., Coggill, P. C., Eberhardt, R. Y., Mistry, J., Tate, J., Boursnell, C., Pang, N., Forslund, K., Ceric, G., Clements, J., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1065 · Cited by 3,719
Nouvelles recherches sur la distribution florale
Jaccard, P. (1908) · E-Periodica · doi:10.5169/seals-268384 · Cited by 3,316
DrugBank: a knowledgebase for drugs, drug actions and drug targets
Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,861
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Donepezil for dementia due to Alzheimer’s disease.
Birks, J. S., & Harvey, R. J. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub3 · Cited by 1,200
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Bipartite network projection and personal recommendation
Zhou, T., Ren, J., Medo, M., & Zhang, Y.-C. (2007) · Physical Review E · doi:10.1103/physreve.76.046115 · Cited by 1,088
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 934
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
PREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Zhou, W., Huang, J., & Tang, Y. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002503 · Cited by 818
Discovery of drug mode of action and drug repositioning from transcriptional responses
Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R., Murino, L., Tagliaferri, R., Brunetti-Pierri, N., Isacchi, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000138107 · Cited by 816
SuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647
Supervised prediction of drug–target interactions using bipartite local models
Bleakley, K., & Yamanishi, Y. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp433 · Cited by 628
Toward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 559
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Yamanishi, Y., Kotera, M., Kanehisa, M., & Goto, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq176 · Cited by 470
Similarity-based machine learning methods for predicting drug–target interactions: a brief review
Ding, H., Takigawa, I., Mamitsuka, H., & Zhu, S. (2014) · Briefings in Bioinformatics · doi:10.1093/bib/bbt056 · Cited by 427
Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces
Xia, Z., Wu, L.-Y., Zhou, X., & Wong, S. T. (2010) · BMC Systems Biology · doi:10.1186/1752-0509-4-s2-s6 · Cited by 389
Gönen, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts360 · Cited by 383
Drug–target interaction prediction by learning from local information and neighbors
Mei, J.-P., Kwoh, C.-K., Yang, P., Li, X.-L., & Zheng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts670 · Cited by 382
Self-citationProtein-ligand interaction prediction: an improved chemogenomics approach
Jacob, L., & Vert, J.-P. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn409 · Cited by 378
Classification of scaffold-hopping approaches
Sun, H., Tawa, G., & Wallqvist, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.024 · Cited by 375
Database resources of the National Center for Biotechnology Information
Wheeler, D. L. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj158 · Cited by 370
LIBLINEAR: A Library for Large Linear Classification
FanRong-En, ChangKai-Wei, HsiehCho-Jui, WangXiang-Rui, & LinChih-Jen (2008) · Journal of Machine Learning Research · doi:10.5555/1390681.1442794 · Cited by 328
Metz, J. T., Johnson, E. F., Soni, N. B., Merta, P. J., Kifle, L., & Hajduk, P. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.530 · Cited by 311
Toward in silico structure-based ADMET prediction in drug discovery
Moroy, G., Martiny, V. Y., Vayer, P., Villoutreix, B. O., & Miteva, M. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.023 · Cited by 302
Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features
He, Z., Zhang, J., Shi, X.-H., Hu, L.-L., Kong, X., Cai, Y.-D., & Chou, K.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009603 · Cited by 288
Donepezil for dementia due to Alzheimer's disease
Birks, J., & Harvey, R. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190.pub2 · Cited by 285
INDI: a computational framework for inferring drug interactions and their associated recommendations
Gottlieb, A., Stein, G. Y., Oron, Y., Ruppin, E., & Sharan, R. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.26 · Cited by 277
Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile
van Laarhoven, T., & Marchiori, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066952 · Cited by 246
Predicting drug side-effect profiles: a chemical fragment-based approach
Pauwels, E., Stoven, V., & Yamanishi, Y. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-169 · Cited by 231
Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218
Predicting drug-target interactions using restricted Boltzmann machines
Wang, Y., & Zeng, J. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt234 · Cited by 211
Relating drug–protein interaction network with drug side effects
Mizutani, S., Pauwels, E., Stoven, V., Goto, S., & Yamanishi, Y. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts383 · Cited by 211
Measuring semantic similarity between Gene Ontology terms
Couto, F. M., Silva, M. J., & Coutinho, P. M. (2007) · Data & Knowledge Engineering · doi:10.1016/j.datak.2006.05.003 · Cited by 201
Drug–target interaction prediction through domain-tuned network-based inference
Alaimo, S., Pulvirenti, A., Giugno, R., & Ferro, A. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt307 · Cited by 170
Analysis of multiple compound–protein interactions reveals novel bioactive molecules
Yabuuchi, H., Niijima, S., Takematsu, H., Ida, T., Hirokawa, T., Hara, T., Ogawa, T., Minowa, Y., Tsujimoto, G., & Okuno, Y. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.5 · Cited by 153
Modulatory profiling identifies mechanisms of small molecule-induced cell death
Wolpaw, A. J., Shimada, K., Skouta, R., Welsch, M. E., Akavia, U. D., Pe'er, D., Shaik, F., Bulinski, J. C., & Stockwell, B. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106149108 · Cited by 133
A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks
Chen, H., & Zhang, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062975 · Cited by 120
DINIES: drug–target interaction network inference engine based on supervised analysis
Yamanishi, Y., Kotera, M., Moriya, Y., Sawada, R., Kanehisa, M. I., & Goto, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku337 · Cited by 116
Carrella, D., Napolitano, F., Rispoli, R., Miglietta, M. M., Carissimo, A., Cutillo, L., Sirci, F., Gregoretti, F., & di Bernardo, D. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu058 · Cited by 86
Kernel-based data fusion improves the drug–protein interaction prediction
Wang, Y., Zhang, C., Deng, N.-Y., & Wang, Y. (2011) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2011.10.003 · Cited by 70
Hu, Y., & Bajorath, J. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300274c · Cited by 63
Scalable prediction of compound-protein interactions using minwise hashing
Tabei, Y., & Yamanishi, Y. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-s6-s3 · Cited by 44
Ernst Schering Research Foundation Workshop
Lessl, M., & Chwalisż, K. (2010) · Cited by 41
Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer
Jaeger, S. A., Min, J., Nigsch, F., Camargo, M. L., Hutz, J., Cornett, A., Cleaver, S. H., Buckler, A., & Jenkins, J. L. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114522690 · Cited by 35
Cited by
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688
Lee, I., Keum, J., & Nam, H. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007129 · Cited by 675
Chen, L., Tan, X., Wang, D., Zhong, F., Liu, X., Yang, T., Luo, X., Chen, K., Jiang, H., & Zheng, M. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa524 · Cited by 607
Rifaioglu, A. S., Atas, H., Martin, M. J., Cetin-Atalay, R., Atalay, V., & Doğan, T. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby061 · Cited by 529
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Metadata
- Authors
- Liu, H., Sun, J., Guan, J., Zheng, J., & Zhou, S.
- Venue
- Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-10
- Volume
- 31
- Issue
- 12
- Pages
- i221-i229
- ISSN
- 1367-4803 (ISSN-L)
- 1367-4811
- OpenAlex
- W2148145769
- Cited by
- 359
- References
- 57
- FWCI
- 9.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.